PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients-Reference-Cited by-同舟云学术

PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients

Published:2021-01 Issue: Volume:163 Page:105241
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Del Re Marzia,Crucitta Stefania^ORCID,Lorenzini Giulia,De Angelis Claudia,Diodati Lucrezia,Cavallero Diletta,Bargagna Irene,Cinacchi Paola,Fratini Beatrice^ORCID,Salvadori Barbara^ORCID,Ghilli Matteo^ORCID,Roncella Manuela,Fontana Andrea,Danesi Romano^ORCID,Cucchiara Federico

Publisher

Elsevier BV

Subject

Pharmacology

Reference42 articles.

1. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs;Roskoski;Pharmacol. Res.,2019

2. A unique CDK4/6 inhibitor: current and future therapeutic strategies of abemaciclib;Chong;Pharmacol. Res.,2020

3. ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future;Rozeboom;Am. J. Cancer Res.,2019

4. ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer;Jeselsohn;Nat. Rev. Clin. Oncol.,2015

5. Genomic evolution of breast cancer metastasis and relapse;Yates;Cancer Cell,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Tumor DNA and Survival in Metastatic Breast Cancer;JAMA Network Open;2024-09-05

2. PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer;Cancer Medicine;2024-09

3. Somatic Mutations in Latin American Breast Cancer Patients: A Systematic Review and Meta-Analysis;Diagnostics;2024-01-29

4. Genomic Alterations of Tumors in HER2-Low Breast Cancers;International Journal of Molecular Sciences;2024-01-21

5. The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management;Cancers;2023-11-17